Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Methyl 3-(bromomethyl)benzoate → 3-{4-[1-(5-Chloro-thiophen-2-ylmethyl)-1H-indol-3-yl]-piperidin-1-ylmethyl}-benzoic acid
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Methyl 3-(bromomethyl)benzoate | HCID 517981 | — |
| 반응물 | 1-(5-chloro-thiophen-2-ylmethyl)-3-piperidin-4-yl-1H-indole | HCID 11370934 | — |
| 생성물 | 3-{4-[1-(5-Chloro-thiophen-2-ylmethyl)-1H-indol-3-yl]-piperidin-1-ylmethyl}-benzoic acid | HCID 10205121 | — |
반응 단계
This compound was prepared following the procedure described in example 19 (part C) starting with 1.48 mmol (4.48 mmol) of 1-(5-chloro-thiophen-2-ylmethyl)-3-piperidin-4-yl-1H-indole and 1.0 g (8.8 mmol) of 3-bromomethyl-benzoic acid methyl ester. The crude mixture was purified by flash chromatography over silica gel affording 0.29 g (14% of yield) of the pure acid.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07189741B2 |
| 출처 데이터셋 | uspto-grants-2007_03 |
| ORD ID | ord-5d653f455822488980d936ec3843bf98 |
| 출처 메모 | uspto-grants-2007_03 |